HER2 + Breast Cancer

specific

A biologic subset of breast carcinoma defined by high expression of HER2, GRB7, and TRAP100, and by lack of expression of estrogen receptor (ER).

Centers

Active Trials

—

Cancer Funding

Top Centers for HER2 + Breast Cancer(27)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive High-Volume Research Center	High-Volume Research Center	4	—	71.9
2	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive High-Volume Research Center	High-Volume Research Center	4	—	71.9
3	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive High-Volume Research Center	High-Volume Research Center	4	—	71.9
4	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	3	—	62.7
5	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	3	—	62.7
6	Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program	Active Research Program	3	—	62.7
7	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	3	—	62.7
8	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	3	—	62.7
9	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	3	—	62.7
10	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	3	—	62.7
11	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	3	—	62.7
12	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program	Active Research Program	2	—	52.7
13	UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	52.7
14	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive Active Research Program	Active Research Program	2	—	52.7
15	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program	Active Research Program	2	—	52.7
16	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program	Active Research Program	1	—	41.0
17	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	1	—	41.0
18	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	41.0
19	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive Active Research Program	Active Research Program	1	—	41.0
20	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	1	—	41.0
21	Stephenson Cancer CenterOklahoma City, OK NCI Clinical Active Research Program	Active Research Program	1	—	41.0
22	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program	Active Research Program	1	—	41.0
23	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	1	—	41.0
24	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	1	—	41.0
25	Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program	Active Research Program	1	—	41.0
26	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive		—	—	31.0
27	Moffitt Cancer CenterTampa, FL NCI Comprehensive		—	—	31.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →